FindTrial
Sign In

A multicenter prospective observational study to evaluate the role of lymph nodal metastases and lymphadenectomy in the surgical treatment of thymic tumors

A multicenter prospective observational study to evaluate the role of lymph nodal metastases and lymphadenectomy in the surgical treatment of thymic tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16009163
Enrollment
Unknown
Registered
2016-09-06
Start date
2014-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thymic tumor

Interventions

1:lymph node dissection or sample

Sponsors

Shanghai Chest Hospital, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with thymic malignancies of all histology and stage, without any pretreatment for the tumor, who underwent surgical resection with an intention for cure.

Exclusion criteria

Exclusion criteria: Patients with induction chemo and/or radiation therapy before operation, or patients underwent surgical biopsy, debulking, or tumor resection only.

Design outcomes

Primary

MeasureTime frame
Incidence of lymph nodal involvement;—

Secondary

MeasureTime frame
Complication rate;—

Countries

China

Contacts

Public ContactWentao Fang

Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University

vwtfang12@shchest.org+86 18017321389

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026